Abstract
Protein-protein interactions (PPIs) have a pivotal role in many biological processes suggesting that targeting macromolecular complexes will open new avenues for the design of the next generation of therapeutics. A wide range of “in silico methods” can be used to facilitate the design of protein-protein modulators. Among these methods, virtual ligand screening, protein-protein docking, structural predictions and druggable pocket predictions have become established techniques for hit discovery and optimization. In this review, we first summarize some key data about proteinprotein interfaces and introduce some recently reported computer methods pertaining to the field. URLs for several recent free packages or servers are also provided. Then, we discuss four studies aiming at developing PPI modulators through the combination of in silico and in vitro screening experiments.
Keywords: virtual ligand screening, structure-based drug design, docking, scoring, drug discovery, protein-protein interaction
Current Pharmaceutical Biotechnology
Title: In Silico-In Vitro Screening of Protein-Protein Interactions: Towards the Next Generation of Therapeutics
Volume: 9 Issue: 2
Author(s): Bruno O. Villoutreix, Karine Bastard, Olivier Sperandio, Robin Fahraeus, Jean-Luc Poyet, Fabien Calvo, Benoit Deprez and Maria A. Miteva
Affiliation:
Keywords: virtual ligand screening, structure-based drug design, docking, scoring, drug discovery, protein-protein interaction
Abstract: Protein-protein interactions (PPIs) have a pivotal role in many biological processes suggesting that targeting macromolecular complexes will open new avenues for the design of the next generation of therapeutics. A wide range of “in silico methods” can be used to facilitate the design of protein-protein modulators. Among these methods, virtual ligand screening, protein-protein docking, structural predictions and druggable pocket predictions have become established techniques for hit discovery and optimization. In this review, we first summarize some key data about proteinprotein interfaces and introduce some recently reported computer methods pertaining to the field. URLs for several recent free packages or servers are also provided. Then, we discuss four studies aiming at developing PPI modulators through the combination of in silico and in vitro screening experiments.
Export Options
About this article
Cite this article as:
Villoutreix O. Bruno, Bastard Karine, Sperandio Olivier, Fahraeus Robin, Poyet Jean-Luc, Calvo Fabien, Deprez Benoit and Miteva A. Maria, In Silico-In Vitro Screening of Protein-Protein Interactions: Towards the Next Generation of Therapeutics, Current Pharmaceutical Biotechnology 2008; 9 (2) . https://dx.doi.org/10.2174/138920108783955218
DOI https://dx.doi.org/10.2174/138920108783955218 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
More Effective DPP4 Inhibitors as Antidiabetics Based on Sitagliptin Applied QSAR and Clinical Methods
Current Computer-Aided Drug Design Discovery of Highly Potent Small Molecule Kallikrein Inhibitors
Medicinal Chemistry A Case of Pantoprazole Anaphylaxis with Cross Reactivity to All Proton Pump Inhibitors: Finding a Safe Alternative
Current Drug Safety Adverse Effects of Antihistamines on Skin Tests and Antihistamines in Pregnancy
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Guanylyl Cyclase Inhibition by MB as Vasoplegic Circulatory Shock Therapeutical Target
Current Drug Targets Renin Angiotensin System (RAS) and Immune System Profile in Specific Subgroups with COVID-19
Current Medicinal Chemistry The Emerging Role of Bradykinin in the Pathogenesis of Osteoarthritis and its Possible Clinical Implications
Current Rheumatology Reviews The Dietary Paradox in Food Allergy: Yesterday's Mistakes, Today's Evidence and Lessons for Tomorrow
Current Pharmaceutical Design Current and Future Chemotherapy for Chagas Disease
Current Medicinal Chemistry Antibodies Against Complement System in SLE and their Potential Diagnostic Utility
Current Rheumatology Reviews Factors Associated with Self-Reported Drug Allergies in a Large Chronic Spontaneous Urticaria Cohort
Current Drug Safety Editorial [Hot Topic: An Update on the Diagnosis of Allergic and Non-Allergic Drug Hypersensitivity (Executive Editors: M.T. Ventura and A. Romano) ]
Current Pharmaceutical Design Cytokine and Nitric Oxide Production Following Severe Envenomation
Current Drug Targets - Inflammation & Allergy Anti-Inflammatory Drugs and Herbs with Special Emphasis on Herbal Medicines for Countering Inflammatory Diseases and Disorders - A Review
Recent Patents on Inflammation & Allergy Drug Discovery An Update on the Immunological, Metabolic and Genetic Mechanisms in Drug Hypersensitivity Reactions
Current Pharmaceutical Design Gene Patents in the Primary Prevention of Vascular Diseases
Recent Patents on DNA & Gene Sequences Efficacy and Safety of Nonopioid Analgesics in Perioperative Pain Control
Current Drug Safety Natural Rubber Latex Allergy in Pediatric Patients
Current Pediatric Reviews Advances in the Development of Bradykinin Receptor Ligands
Current Topics in Medicinal Chemistry Hypertension in Hemodialysis Patients
Current Hypertension Reviews